Tiragolumab and atezolizumab for head and neck neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Aug 2022: Trial registered, NCT05483400
  2. 18 Oct 2023: Trial started, NCT05483400

The trials

NCT05483400: Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors

State
Under way
Phase
Phase 2
People
97 planned
Started
18 Oct 2023
Primary completion
Sep 2025
Arms
Localized Head and Neck Squamous Cell Cancer, Advanced or Metastatic dMMR/MSI Cancer, Anti-PD-1 Antibody Resistant Metastatic Melanoma, Basket
Results
None posted
  1. 2 Aug 2022: Trial registered
  2. 18 Oct 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.